Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,018
Closed -$2.52M 149
2025
Q4
$2.52M Sell
11,018
-3,272
-23% -$683K 0.97% 37
2025
Q3
$2.3M Hold
14,290
0.82% 53
2025
Q2
$2.41M Sell
14,290
-2,442
-15% -$381K 0.91% 42
2025
Q1
$2.37M Sell
16,732
-274
-2% -$44K 0.96% 46
2024
Q4
$2.69M Sell
17,006
-3,800
-18% -$554K 0.91% 47
2024
Q3
$2.64M Sell
20,806
-8,594
-29% -$987K 0.91% 47
2024
Q2
$3.18M Sell
29,400
-7,265
-20% -$738K 1.16% 29
2024
Q1
$3.35M Sell
36,665
-7,824
-18% -$588K 1.07% 39
2023
Q4
$2.79M Sell
44,489
-10,100
-19% -$505K 0.89% 46
2023
Q3
$2.42M Sell
54,589
-616
-1% -$31.4K 0.82% 50
2023
Q2
$2.69M Sell
55,205
-10,805
-16% -$551K 0.86% 46
2023
Q1
$3.66M Buy
+66,010
New +$3.17M 1.18% 25
2016
Q1
Sell
-10,000
Closed -$108K 169
2015
Q4
$108K Buy
+10,000
New +$95.1K 0.03% 165

Other funds holding NTRA

Formula Growth's NTRA Position: Q1 2026 in Review

Formula Growth sold out of Natera (NTRA) in Q1 2026, closing a stake of 11,018 shares — an estimated $2.52M sold.

Formula Growth first reported a position in NTRA in Q4 2015 and held it in 13 quarters. The position peaked at $3.66M in Q1 2023. 765 funds tracked by Wall St. Rank hold NTRA as of Q1 2026.

  • Formula Growth reported no remaining Natera position as of Q1 2026 after selling out during the quarter.
  • Formula Growth sold 11,018 Natera shares in Q1 2026, an estimated $2.52M.
  • Formula Growth first reported a position in Natera in Q4 2015 and held it in 13 quarters.
  • Formula Growth's Natera position peaked at $3.66M in Q1 2023.
  • 765 funds tracked by Wall St. Rank held Natera as of Q1 2026.

Based on Formula Growth's 13F filing for Q1 2026, filed 14 May 2026.